Observational studyHistopathology2022

Evaluating programmed death-ligand 1 (PD-L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study.

Bruna Cerbelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.